Mrna-1345

2 trials

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

0 Recruiting

2 Completed trials

1 Sponsors

4 Countries

Phase II

Phase I (Other)

Phase II: 1 Phase I (Other): 1

Oversight events:

1 serious breach 2 temporary halts 1 unexpected event across 2 trials

View oversight register →

Sponsors using this IMP

All trials

2 total

A study to investigate the reactogenicity, safety, and immunogenicity of mRNA-1345 in pregnant women, and safety and immunogenicity in their… Ended

2023-505359-37-00 Phase II 1 country Moderna Inc.
A Safety, Tolerability, and Immunogenicity Study of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to <24 Months Ended

2022-502022-41-00 Phase I (Other) 3 countries Moderna Inc.

Showing 1–2 of 2 trials

← All drugs A–Z